Literature DB >> 19506563

The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.

T J Wilkin1.   

Abstract

Although some 40 years have passed since type I diabetes was first defined, its cause remains unknown. The autoimmunity paradigm of immune dysregulation has not offered an explanation for its rising incidence, nor means of preventing it, and there is arguably good reason to consider alternatives. The accelerator hypothesis is a singular, unifying concept that argues that type I and type II diabetes are the same disorder of insulin resistance, set against different genetic backgrounds. The hypothesis does not deny the role of autoimmuniy, only its primacy in the process. It distinguishes type I and type II diabetes only by tempo, the faster tempo reflecting the more susceptible genotype and (inevitably) earlier presentation. Insulin resistance is closely related to the rise in overweight and obesity, a trend that the hypothesis deems central to the rising incidence of all diabetes in the developed and developing world. Rather than overlap between the two types of diabetes, the accelerator hypothesis envisages overlay-each a subset of the general population differing from each other only by genotype. Indeed, it views type I and type II diabetes as a continuum, where the infinitely variable interaction between insulin resistance and genetic response determines the age at which beta-cell loss becomes critical. Adult diabetes is not viewed as an entity, but rather as diabetes presenting in adulthood. Childhood diabetes, similarly, is diabetes presenting in childhood. The increasing incidence of both is primarily the result of lifestyle change and the rise in body weight that has resulted.

Entities:  

Mesh:

Year:  2009        PMID: 19506563     DOI: 10.1038/ijo.2009.97

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  33 in total

1.  Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice.

Authors:  Susan J Burke; Heidi M Batdorf; Adrianna E Eder; Michael D Karlstad; David H Burk; Robert C Noland; Z Elizabeth Floyd; J Jason Collier
Journal:  Am J Pathol       Date:  2017-01-04       Impact factor: 4.307

2.  Interaction Between Overweight and Genotypes of HLA, TCF7L2, and FTO in Relation to the Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.

Authors:  Rebecka Hjort; Josefin E Löfvenborg; Emma Ahlqvist; Lars Alfredsson; Tomas Andersson; Valdemar Grill; Leif Groop; Elin P Sørgjerd; Tiinamaija Tuomi; Bjørn Olav Åsvold; Sofia Carlsson
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 3.  Connecting type 1 and type 2 diabetes through innate immunity.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 4.  Is autoimmunity or insulin resistance the primary driver of type 1 diabetes?

Authors:  Terence J Wilkin
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 5.  Type 2 diabetes in childhood: clinical characteristics and role of β-cell autoimmunity.

Authors:  Angela Badaru; Catherine Pihoker
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

6.  The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes.

Authors:  Maria J Redondo; Carmella Evans-Molina; Andrea K Steck; Mark A Atkinson; Jay Sosenko
Journal:  Diabetes Care       Date:  2019-06-04       Impact factor: 19.112

Review 7.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

8.  Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to 2005.

Authors:  S Sipetic; J Maksimovic; H Vlajinac; I Ratkov; S Sajic; D Zdravkovic; T Sipetic
Journal:  J Endocrinol Invest       Date:  2012-09-24       Impact factor: 4.256

Review 9.  Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?

Authors:  S J Cleland; B M Fisher; H M Colhoun; N Sattar; J R Petrie
Journal:  Diabetologia       Date:  2013-04-24       Impact factor: 10.122

10.  Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children.

Authors:  Valentina M Cambuli; Michela Incani; Efisio Cossu; Tiziana Congiu; Francesca Scano; Sabrina Pilia; Federica Sentinelli; Claudio Tiberti; M Gisella Cavallo; Sandro Loche; Marco G Baroni
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.